Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices 29703 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; RFA AT09–002 

Translational Tools for Clinical Studies of 

CAM Interventions. 

Date: July 15, 2009. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Ray Bramhall, PhD, 

Scientific Review Officer, National Center for 

Complementary and Alternative Medicine, 

6707 Democracy Blvd., Suite 401, Bethesda, 

MD 20892, bramhallr@mail.nih.gov. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Botanical Centers. 

Date: August 2–3, 2009. 

Time: 5 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Marriott Washingtonian 

Center, 204 Boardwalk Place, Gaithersburg, 

MD 20814. 

Contact Person: Martina Schmidt, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Center for Complementary 

& Alternative Medicine, NIH, 6707 

Democracy Blvd., Suite 401, Bethesda, MD 

20892, 301–594–3456, 

schmidma@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: June 17, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–14701 Filed 6–22–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): American 

Recovery and Reinvestment Act 

(ARRA)-Section 317 Immunization 

Program: Strengthening the Evidence 

Base Measuring Effectiveness of Two 

Dose of Varicella Vaccine, Funding 

Opportunity Announcement (FOA) 

IP04–11601ARRA09, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 12 p.m.–2 p.m., July 28, 

2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘ARRA-Section 317 

Immunization Program: Strengthening the 

Evidence Base Measuring Effectiveness of 

Two Dose of Varicella Vaccine, FOA IP04– 

11601ARRA09.’’ 

For More Information Contact: Wendy 

Carr, PhD, CDC, 1600 Clifton Road, NE., 

Mailstop E60, Atlanta, GA 30333, Telephone: 

(404) 498–2276. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: June 12, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office Centers for Disease Control and 

Prevention. 

[FR Doc. E9–14664 Filed 6–22–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Translating 

Research To Protect Health Through 

Health Promotion, Prevention, and 

Preparedness, Panel D, Funding 

Opportunity Announcement (FOA) 

CD09–001, Initial Review 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 9 a.m.–5 p.m., July 21, 

2009 (Closed). 9 a.m.–1 p.m., July 22, 2009 

(Closed). 

Place: W Hotel, Midtown, 188 14th Street, 

NE., Atlanta, Georgia 30361, Telephone: 

(404) 892–6000. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Translating Research to 

Protect Health through Health Promotion, 

Prevention, and Preparedness, Panel D, FOA 

CD09–001, initial review.’’ 

For More Information Contact: Christine J. 

Morrison, PhD, Scientific Review 

Administrator, CDC, 1600 Clifton Road, NE., 

Mailstop D72, Atlanta, GA 30333, Telephone 

(404) 639–3098. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: June 15, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–14659 Filed 6–22–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Notice of Hearing: Reconsideration of 

Disapproval of Washington State Plan 

Amendment (SPA) 08–019 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of Hearing.